Advertisement
YOU ARE HERE: LAT HomeCollectionsUrokinasem Enzyme
IN THE NEWS

Urokinasem Enzyme

FEATURED ARTICLES
CALIFORNIA | LOCAL
February 17, 1993 | LESLIE BERKMAN, TIMES STAFF WRITER
Rapid treatment with a clot-dissolving drug may stop or even reverse brain damage caused by strokes, according to a team of physician researchers at the UCI Medical Center. Dr. Larry-Stuart Deutsch, the medical center's chief of cardiovascular and interventional radiology, said one stroke victim, an 18-year-old woman, so far has been treated by the researchers with the clot-dissolving drug urokinaseM, an enzyme.
ARTICLES BY DATE
CALIFORNIA | LOCAL
October 11, 1993 | JEFF BRAZIL, TIMES STAFF WRITER
If it was true that she might never walk normally again. If she would never be able to talk, to say so much as "good morning" to a neighbor. If she would never again have the strength to pick up her newborn baby and cradle him in her arms. Then, risks or no, she wanted to take the chance, to try an aggressive new treatment for stroke victims. It was noon on Aug. 31, a Tuesday, and Tracy Houston, 36, was lying on a gurney at UCI Medical Center.
Advertisement
CALIFORNIA | LOCAL
October 11, 1993 | JEFF BRAZIL, TIMES STAFF WRITER
If it was true that she might never walk normally again. If she would never be able to talk, to say so much as "good morning" to a neighbor. If she would never again have the strength to pick up her newborn baby and cradle him in her arms. Then, risks or no, she wanted to take the chance, to try an aggressive new treatment for stroke victims. It was noon on Aug. 31, a Tuesday, and Tracy Houston, 36, was lying on a gurney at UCI Medical Center.
CALIFORNIA | LOCAL
February 17, 1993 | LESLIE BERKMAN, TIMES STAFF WRITER
Rapid treatment with a clot-dissolving drug may stop or even reverse brain damage caused by strokes, according to a team of physician researchers at the UCI Medical Center. Dr. Larry-Stuart Deutsch, the medical center's chief of cardiovascular and interventional radiology, said one stroke victim, an 18-year-old woman, so far has been treated by the researchers with the clot-dissolving drug urokinaseM, an enzyme.
Los Angeles Times Articles
|